메뉴 건너뛰기
Journal of Thrombosis and Haemostasis
Volumn 1, Issue 12, 2003, Pages 2698-2699
Choice of replacement therapy for hemophilia-a rebuttal
Author keywords

[No Author keywords available]
Indexed keywords

BLOOD CLOTTING FACTOR; CITRIC ACID; CRYOPROTECTIVE AGENT; RECOMBINANT PROTEIN;
EID: 1542755055     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2003.0543n.x     Document Type: Letter
Times cited : (2)
References (4)
  • 1
    • 0141673367 scopus 로고    scopus 로고
    • Treatment of haemophilia: recombinant factors only? Yes
    • Giangrande PLF. Treatment of haemophilia: recombinant factors only? Yes. J Thromb Haemost 2003; 1: 213.
    • (2003) J Thromb Haemost , vol.1 , pp. 213
    • Giangrande, P.L.F.1
  • 2
    • 0642341976 scopus 로고    scopus 로고
    • Choice of replacement therapy for hemophilia
    • Aledort LM. Choice of replacement therapy for hemophilia. J Thromb Haemost 2003; 1: 596.
    • (2003) J Thromb Haemost , vol.1 , pp. 596
    • Aledort, L.M.1
  • 3
    • 84858652799 scopus 로고    scopus 로고
    • Choice of replacement therapy for hemophilia
    • Roberts HR. Choice of replacement therapy for hemophilia. J Thromb Haemost 2003; 1: 595.
    • (2003) J Thromb Haemost , vol.1 , pp. 595
    • Roberts, H.R.1
  • 4
    • 27844500722 scopus 로고    scopus 로고
    • 'Super-cryoprecipitate': anew, safer method of producing plasma-derived plasma-derived factor VIII
    • (Abstract 407)
    • Owens WJ, ShanbromE. 'Super-cryoprecipitate': anew, safer method of producing plasma-derived plasma-derived factor VIII. Vox Sanguinis 2002; 83 (Suppl. 2): 137 (Abstract 407).
    • (2002) Vox Sanguinis , vol.83 , Issue.SUPPL. 2 , pp. 137
    • Owens, W.J.1    Shanbrom, E.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.